Ron Bacon will be hiking the Pacific Crest Trail over the next six years on a section by section basis in an effort to support Breast Cancer Care & Research Fund. Ron is a school teacher who will be hking during his school breaks throughout the year for the next six years.
You can see Ron's six year plan at his website,www.hike2help.org and as directed return to this website to make your donation. You can also mail it directly to:
Breast Cancer Care & Research Fund
6022 Wilshire Boulevard Suite 201
Los Angeles, CA 90036
(310)927-7606
SPECIAL REPORT: The 30th Annual San Antonio Breast Cancer Symposium
More than 8,500 physicians, researchers, and advocates from 76 countries convened in San Antonio, Texas, December 13-16, 2007, to share the latest clinical trial findings and basic science advancing knowledge and treatment of breast cancer. In a world so shattered by war, disease and poverty, this symposium always stands out as a shining example of people’s capacity to act as global citizens and work together to improve health and quality of life for all.
Mary Billings, Patient Advocate
San Antonio Breast Cancer Symposium BCCRF Scholarship recipient 2007.
Kim Tankersley, Breast Cancer Care and Research Fund Scholarship Recipient, 2007
30th Annual San Antonio Breast Cancer Symposium
Henry B. Gonzalez Convention Center, San Antonio, Texas, USA
December 13-16, 2007
SPECIAL REPORT: New Drug Breakthrough for Advanced Breast Cancer
Lapatinib, an experimental drug with the brand name Tykerb, promises to become a major treatment option and perhaps a new standard of care for women with HER2/neu-positive breast cancer that becomes resistant to trastuzumab (Herceptin).
Ron Bacon will be hiking the Pacific Crest Trail over the next six years on a section by section basis in an effort to support Breast Cancer Care & Research Fund. Ron is a school teacher who will be hking during his school breaks throughout the year for the next six years.
More than 8,500 physicians, researchers, and advocates from 76 countries convened in San Antonio, Texas, December 13-16, 2007, to share the latest clinical trial findings and basic science advancing knowledge and treatment of breast cancer. In a world so shattered by war, disease and poverty, this symposium always stands out as a shining example of people’s capacity to act as global citizens and work together to improve health and quality of life for all.
San Antonio Breast Cancer Symposium BCCRF Scholarship recipient 2007.
This was my first year attending the San Antonio Breast Cancer Symposium (SABCS). No words could have prepared me for the magnitude of the event.
A new study from Dutch researchers finds gene profile of breast cancers likely to metastasize to bone.
TO BENEFIT
Lapatinib, an experimental drug with the brand name Tykerb, promises to become a major treatment option and perhaps a new standard of care for women with HER2/neu-positive breast cancer that becomes resistant to trastuzumab (Herceptin).